fulvestrant has been researched along with Cardiac Failure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorn, GW; Liao, JK; Matter, CM; Ogita, H; Satoh, M; Takeshita, K; Wang, CY | 1 |
1 other study(ies) available for fulvestrant and Cardiac Failure
| Article | Year |
|---|---|
Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen.
Topics: Acetophenones; Angiotensin II; Animals; Apoptosis; Cardiomyopathy, Dilated; Cell Size; Cytosol; Dicarboxylic Acids; Drug Implants; Estradiol; Estrogen Receptor Modulators; Fulvestrant; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Hydrogen Peroxide; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase Kinase 5; Membrane Proteins; Mice; Mice, Transgenic; Mitochondria; Myocytes, Cardiac; NADPH Oxidases; Neuropeptides; Oxidation-Reduction; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; Rats; Superoxides; Thioredoxin Reductase 1; Thioredoxin Reductase 2; Thioredoxin-Disulfide Reductase; Thioredoxins | 2007 |